{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:45:16Z","timestamp":1794861916849,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["CA203991"],"award-info":[{"award-number":["CA203991"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["CA203991"],"award-info":[{"award-number":["CA203991"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TRAIL specifically induces apoptosis in cancer cells without affecting healthy cells. However, TRAIL\u2019s cancer cytotoxicity was insufficient in clinical trials. Circulatory-shear stress is known to sensitize cancer cells to TRAIL. In this study, we examine the mechanism of this TRAIL sensitization with the goal of translating it to static conditions. GsMTx-4, a Piezo1 inhibitor, was found to reduce shear stress-related TRAIL sensitization, implicating Piezo1 activation as a potential TRAIL-sensitizer. The Piezo1 agonist Yoda1 recreated shear stress-induced TRAIL sensitization under static conditions. A significant increase in apoptosis occurred when PC3, COLO 205, or MDA-MB-231 cells were treated with Yoda1 and TRAIL in combination, but not in Bax-deficient DU145 cells. Calpastatin inhibited apoptosis in Yoda1-TRAIL treated cells, indicating that calpain activation is necessary for apoptosis by Yoda1 and TRAIL. Yoda1 and TRAIL treated PC3 cells showed increased mitochondrial outer membrane permeability (MOMP), mitochondrial depolarization, and activated Bax. This implies that Piezo1 activation sensitizes cancer cells to TRAIL through a calcium influx that activates calpains. The Calpains then induce MOMP by enhancing Bax activation. From these experiments a computational model was developed to simulate apoptosis for cells treated with TRAIL and increased calcium. The computational model elucidated the proapoptotic or antiapoptotic roles of Bax, Bcl-2, XIAP, and other proteins important in the mitochondrial-apoptotic signaling pathway.<\/jats:p>","DOI":"10.1038\/s41419-019-2063-6","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T10:03:15Z","timestamp":1572861795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Activation of Piezo1 sensitizes cells to TRAIL-mediated apoptosis through mitochondrial outer membrane permeability"],"prefix":"10.1038","volume":"10","author":[{"given":"Jacob M.","family":"Hope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lopez-Cavestany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0907-6282","authenticated-orcid":false,"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6959-3914","authenticated-orcid":false,"given":"Cynthia A.","family":"Reinhart-King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"2063_CR1","doi-asserted-by":"crossref","unstructured":"Stewart, B. W. & Wild, C. P. World cancer report 2014. (2014).","DOI":"10.12968\/nuwa.2014.10.2.1142051"},{"key":"2063_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley, S. R. et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673\u2013682 (1995).","journal-title":"Immunity"},{"key":"2063_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1128\/MCB.20.1.205-212.2000","volume":"20","author":"SB Gibson","year":"2000","unstructured":"Gibson, S. B., Oyer, R., Spalding, A. C., Anderson, S. M. & Johnson, G. L. Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol. Cell. Biol. 20, 205\u2013212 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"2063_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nrd2637","volume":"7","author":"A Ashkenazi","year":"2008","unstructured":"Ashkenazi, A. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat. Rev. Drug Discov. 7, 1001\u20131012 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2063_CR5","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/S2352-3026(15)00026-5","volume":"2","author":"CY Cheah","year":"2015","unstructured":"Cheah, C. Y. et al. Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b\/2 randomised study. Lancet Haematol. 2, e166\u2013e174 (2015).","journal-title":"Lancet Haematol."},{"key":"2063_CR6","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1200\/JCO.2009.25.4847","volume":"28","author":"J-C Soria","year":"2010","unstructured":"Soria, J.-C. et al. Phase 1b study of Dulanermin (recombinant human Apo2L\/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non\u2013small-cell lung cancer. J. Clin. Oncol. 28, 1527\u20131533 (2010).","journal-title":"J. Clin. Oncol."},{"key":"2063_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/sj.bjc.6605507","volume":"102","author":"T Trarbach","year":"2010","unstructured":"Trarbach, T. et al. Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer. Br. J. Cancer 102, 506\u2013512 (2010).","journal-title":"Br. J. Cancer"},{"key":"2063_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/cdd.2014.81","volume":"21","author":"J Lemke","year":"2014","unstructured":"Lemke, J., von Karstedt, S., Zinngrebe, J. & Walczak, H. Getting TRAIL back on track for cancer therapy. Cell Death Differ. 21, 1350\u20131364 (2014).","journal-title":"Cell Death Differ."},{"key":"2063_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.neo.7900270","volume":"4","author":"N \u00d6z\u00f6ren","year":"2002","unstructured":"\u00d6z\u00f6ren, N. & El-Deiry, W. S. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Neoplasia N. Y. N. 4, 551\u2013557 (2002).","journal-title":"Neoplasia N. Y. N."},{"key":"2063_CR10","doi-asserted-by":"publisher","first-page":"a008672","DOI":"10.1101\/cshperspect.a008672","volume":"5","author":"AB Parrish","year":"2013","unstructured":"Parrish, A. B., Freel, C. D. & Kornbluth, S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb. Perspect. Biol. 5, a008672 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2063_CR11","doi-asserted-by":"publisher","first-page":"29652","DOI":"10.1074\/jbc.M603487200","volume":"281","author":"AK Samraj","year":"2006","unstructured":"Samraj, A. K., Keil, E., Ueffing, N., Schulze-Osthoff, K. & Schmitz, I. Loss of caspase-9 Provides genetic evidence for the Type I\/II concept of CD95-mediated apoptosis. J. Biol. Chem. 281, 29652\u201329659 (2006).","journal-title":"J. Biol. Chem."},{"key":"2063_CR12","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1074\/jbc.M108171200","volume":"277","author":"M Madesh","year":"2002","unstructured":"Madesh, M., Antonsson, B., Srinivasula, S. M., Alnemri, E. S. & Hajn\u00f3czky, G. Rapid kinetics of tBid-induced cytochrome c and Smac\/DIABLO release and mitochondrial depolarization. J. Biol. Chem. 277, 5651\u20135659 (2002).","journal-title":"J. Biol. Chem."},{"key":"2063_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fonc.2013.00041","volume":"3","author":"DH Suh","year":"2013","unstructured":"Suh, D. H., Kim, M.-K., Kim, H. S., Chung, H. H. & Song, Y. S. Mitochondrial permeability transition pore as a selective target for anti-cancer therapy. Front. Oncol. 3, 41 (2013).","journal-title":"Front. Oncol."},{"key":"2063_CR14","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/sj.onc.1204282","volume":"20","author":"A Suliman","year":"2001","unstructured":"Suliman, A., Lam, A., Datta, R. & Srivastava, R. K. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20, 2122\u20132133 (2001).","journal-title":"Oncogene"},{"key":"2063_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08229","volume":"460","author":"PJ Jost","year":"2009","unstructured":"Jost, P. J. et al. XIAP acts as a switch between type I and type II FAS-induced apoptosis signalling. Nature 460, 1035\u20131039 (2009).","journal-title":"Nature"},{"key":"2063_CR16","doi-asserted-by":"publisher","first-page":"015008","DOI":"10.1088\/1367-2630\/15\/1\/015008","volume":"15","author":"MJ Mitchell","year":"2013","unstructured":"Mitchell, M. J. & King, M. R. Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors. New J. Phys. 15, 015008 (2013).","journal-title":"New J. Phys."},{"key":"2063_CR17","doi-asserted-by":"publisher","first-page":"10347","DOI":"10.1073\/pnas.1409233111","volume":"111","author":"SS Ranade","year":"2014","unstructured":"Ranade, S. S. et al. Piezo1, a mechanically activated ion channel, is required for vascular development in mice. Proc. Natl Acad. Sci USA 111, 10347\u201310352 (2014).","journal-title":"Proc. Natl Acad. Sci USA"},{"key":"2063_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47454","volume":"8","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. The mechanosensitive Piezo1 channel is required for bone formation. eLife 8, e47454 (2019).","journal-title":"eLife"},{"key":"2063_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/PPO.0000000000000312","volume":"24","author":"J Hope","year":"2018","unstructured":"Hope, J., Greenlee, J. & King, M. R. Mechanosensitive ion channels: TRPV4 and P2X7 in disseminating cancer cells. Cancer J. Sudbury Mass 24, 84\u201392 (2018).","journal-title":"Cancer J. Sudbury Mass"},{"key":"2063_CR20","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1038\/onc.2017.234","volume":"36","author":"AA Peters","year":"2017","unstructured":"Peters, A. A. et al. Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells. Oncogene 36, 6490\u20136500 (2017).","journal-title":"Oncogene"},{"key":"2063_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12931-019-1083-1","volume":"20","author":"G-P Liang","year":"2019","unstructured":"Liang, G.-P. et al. Piezo1 induced apoptosis of type II pneumocytes during ARDS. Respir. Res. 20, 118 (2019).","journal-title":"Respir. Res."},{"key":"2063_CR22","doi-asserted-by":"crossref","unstructured":"Syeda, R. et al. Chemical activation of the mechanotransduction channel Piezo1. eLife 4, e07369 (2015).","DOI":"10.7554\/eLife.07369"},{"key":"2063_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059350","volume":"8","author":"PK Sobhan","year":"2013","unstructured":"Sobhan, P. K. et al. Calpain and reactive oxygen species targets Bax for mitochondrial permeabilisation and caspase activation in zerumbone induced apoptosis. PLoS ONE 8, e59350 (2013).","journal-title":"PLoS ONE"},{"key":"2063_CR24","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1074\/jbc.M308576200","volume":"279","author":"F Altznauer","year":"2004","unstructured":"Altznauer, F., Conus, S., Cavalli, A., Folkers, G. & Simon, H.-U. Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J. Biol. Chem. 279, 5947\u20135957 (2004).","journal-title":"J. Biol. Chem."},{"key":"2063_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nsb0402-239","volume":"9","author":"A Khorchid","year":"2002","unstructured":"Khorchid, A. & Ikura, M. How calpain is activated by calcium. Nat. Struct. Biol. 9, 239\u2013241 (2002).","journal-title":"Nat. Struct. Biol."},{"key":"2063_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1083\/jcb.200912070","volume":"188","author":"B Gillissen","year":"2010","unstructured":"Gillissen, B. et al. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma. J. Cell Biol. 188, 851\u2013862 (2010).","journal-title":"J. Cell Biol."},{"key":"2063_CR27","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"2063_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Disco. 2, 401\u2013404 (2012).","journal-title":"Cancer Disco."},{"key":"2063_CR29","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.celrep.2015.10.042","volume":"13","author":"R Palchaudhuri","year":"2015","unstructured":"Palchaudhuri, R. et al. A small molecule that induces intrinsic pathway apoptosis with unparalleled speed. Cell Rep. 13, 2027\u20132036 (2015).","journal-title":"Cell Rep."},{"key":"2063_CR30","first-page":"3976","volume":"53","author":"SH Kaufmann","year":"1993","unstructured":"Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E. & Poirier, G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976\u20133985 (1993).","journal-title":"Cancer Res."},{"key":"2063_CR31","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1097\/CCM.0b013e318246bb5d","volume":"40","author":"WB Nelson","year":"2012","unstructured":"Nelson, W. B. et al. Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation. Crit. Care Med. 40, 1857\u20131863 (2012).","journal-title":"Crit. Care Med."},{"key":"2063_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.emboj.7600544","volume":"24","author":"FL Scott","year":"2005","unstructured":"Scott, F. L. et al. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J. 24, 645\u2013655 (2005).","journal-title":"EMBO J."},{"key":"2063_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883\u2013892 (2012).","journal-title":"N. Engl. J. Med."},{"key":"2063_CR34","doi-asserted-by":"crossref","first-page":"41113","DOI":"10.18632\/oncotarget.17064","volume":"8","author":"R Wang","year":"2017","unstructured":"Wang, R., Jin, C. & Hu, X. Evidence of drug-response heterogeneity rapidly generated from a single cancer cell. Oncotarget 8, 41113\u201341124 (2017).","journal-title":"Oncotarget"},{"key":"2063_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1073\/pnas.1316312111","volume":"111","author":"MJ Mitchell","year":"2014","unstructured":"Mitchell, M. J., Wayne, E., Rana, K., Schaffer, C. B. & King, M. R. TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc. Natl Acad. Sci. USA 111, 930\u2013935 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2063_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fonc.2018.00410","volume":"8","author":"EE Lederman","year":"2018","unstructured":"Lederman, E. E., Hope, J. M. & King, M. R. Mass action kinetic model of apoptosis by TRAIL-functionalized leukocytes. Front. Oncol. 8, 410 (2018).","journal-title":"Front. Oncol."},{"key":"2063_CR37","first-page":"763","volume":"8","author":"Q Huang","year":"2018","unstructured":"Huang, Q. et al. Fluid shear stress and tumor metastasis. Am. J. Cancer Res 8, 763\u2013777 (2018).","journal-title":"Am. J. Cancer Res"},{"key":"2063_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3892\/ijo.2013.2215","volume":"44","author":"M Suzuki-Karasaki","year":"2014","unstructured":"Suzuki-Karasaki, M., Ochiai, T. & Suzuki-Karasaki, Y. Crosstalk between mitochondrial ROS and depolarization in the potentiation of TRAIL-induced apoptosis in human tumor cells. Int. J. Oncol. 44, 616\u2013628 (2014).","journal-title":"Int. J. Oncol."},{"key":"2063_CR39","doi-asserted-by":"publisher","first-page":"12980","DOI":"10.1073\/pnas.1902165116","volume":"116","author":"EE Friedrich","year":"2019","unstructured":"Friedrich, E. E. et al. Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions. Proc. Natl Acad. Sci. USA 116, 12980\u201312985 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2063_CR40","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.144","volume":"1","author":"R Parrondo","year":"2013","unstructured":"Parrondo, R., de las Pozas, A., Reiner, T. & Perez-Stable, C. ABT-737, a small molecule Bcl-2\/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells. PeerJ 1, e144 (2013).","journal-title":"PeerJ"},{"key":"2063_CR41","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1158\/1535-7163.MCT-06-0011","volume":"5","author":"I Kaddour-Djebbar","year":"2006","unstructured":"Kaddour-Djebbar, I. et al. Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer. Mol. Cancer Ther. 5, 1958\u20131966 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"2063_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-6-122","volume":"6","author":"J-Y Hong","year":"2012","unstructured":"Hong, J.-Y. et al. Computational modeling of apoptotic signaling pathways induced by cisplatin. BMC Syst. Biol. 6, 122 (2012).","journal-title":"BMC Syst. Biol."},{"key":"2063_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1126\/science.284.5412.339","volume":"284","author":"H-G Wang","year":"1999","unstructured":"Wang, H.-G. et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284, 339\u2013343 (1999).","journal-title":"Science"},{"key":"2063_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060299","volume":"6","author":"JG Albeck","year":"2008","unstructured":"Albeck, J. G., Burke, J. M., Spencer, S. L., Lauffenburger, D. A. & Sorger, P. K. Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol. 6, e299 (2008).","journal-title":"PLoS Biol."},{"key":"2063_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/bjc.1983.31","volume":"47","author":"RJ Hastings","year":"1983","unstructured":"Hastings, R. J. & Franks, L. M. Cellular heterogeneity in a tissue culture cell line derived from a human bladder carcinoma. Br. J. Cancer 47, 233\u2013244 (1983).","journal-title":"Br. J. Cancer"},{"key":"2063_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biocel.2016.12.001","volume":"83","author":"SS Park","year":"2017","unstructured":"Park, S. S. et al. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. Int. J. Biochem. Cell Biol. 83, 47\u201355 (2017).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2063_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188584","volume":"12","author":"OV Blan\u00e1\u0159ov\u00e1","year":"2017","unstructured":"Blan\u00e1\u0159ov\u00e1, O. V. et al. Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10. PLoS ONE 12, e0188584 (2017).","journal-title":"PLoS ONE"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2063-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2063-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2063-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T12:47:22Z","timestamp":1671194842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2063-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-2063-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"16 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"837"}}